eCite Digital Repository

Purification and properties of beta-lactamase from bacteroides-fragilis


Britz, ML and Wilkinson, RG, Purification and properties of beta-lactamase from bacteroides-fragilis, Antimicrobial Agents and Chemotherapy, 13, (3) pp. 373-382. ISSN 0066-4804 (1978) [Refereed Article]

DOI: doi:10.1128/AAC.13.3.373


β-Lactamase activity was detected either biologically or using the chromogenic cephalosporin 87/312 in 20 clinical isolates of B. fragilis with penicillin G minimal inhibitory concentrations of 10 to 100 μg/ml. Strain AM78 (minimal inhibitory concentration, > 1,000 μg/ml) was used to optimize the conditions for production, assay, and storage of the enzyme. The enzymes are cell associated, with < 1% of activity being found in culture fluids during growth, and can be released from the cell surface by a modified osmotic shock procedure. This procedure causes concomitant release of cyclic phosphodiesterase activity. Substrate profiles and the effects of inhibitors were determined for enzymes partially purified by osmotic shock release and gel filtration. The enzymes are cephalosporinases with some penicillinase activity and are inhibited by p-chloromercuribenzoate, cloxacillin, and carbenicillin. The molecular weight, as determined by gel filtration, is 29,000 to 31,000. A method for the purification of the β-lactamase from strain AM78 is described: the specific activity of the purified enzyme was 3.424 U/mg, about 3,000-fold that of the crude, cell-associated enzyme.

Item Details

Item Type:Refereed Article
Research Division:Biological Sciences
Research Group:Microbiology
Research Field:Bacteriology
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Britz, ML (Professor Margaret Britz)
ID Code:73228
Year Published:1978
Web of Science® Times Cited:45
Deposited By:Research Division
Deposited On:2011-09-22
Last Modified:2011-09-22

Repository Staff Only: item control page